Xenon Pharmaceuticals (XENE) Tops Q4 EPS by 12c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q4 EPS of ($0.64), $0.12 better than the analyst estimate of ($0.76).

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• UBS Upgrades Zhejiang Leapmotor Technology (9863:HK) to Buy
• Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)